These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22093190)

  • 1. Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):87-91. PubMed ID: 22093190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):92-6. PubMed ID: 22093189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
    Sarma AV; Burke JP; Jacobson DJ; McGree ME; St Sauver J; Girman CJ; Lieber MM; Herman W; Macoska J; Montie JE; Jacobsen SJ
    Diabetes Care; 2008 Mar; 31(3):476-82. PubMed ID: 18071006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.
    Sarma AV; St Sauver JL; Hollingsworth JM; Jacobson DJ; McGree ME; Dunn RL; Lieber MM; Jacobsen SJ;
    Urology; 2012 Jan; 79(1):102-8. PubMed ID: 22112286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials.
    Moul JW
    Urology; 2001 Apr; 57(4 Suppl 1):174-7. PubMed ID: 11295620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.
    Sarma AV; St Sauver JL; Jacobson DJ; McGree ME; Klee GG; Lieber MM; Girman CJ; Hollingsworth JM; Jacobsen SJ;
    Urology; 2014 Jan; 83(1):88-93. PubMed ID: 24139354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    Urology; 2012 Mar; 79(3):655-61. PubMed ID: 22386420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.
    Sarma AV; Wei JT; Jacobson DJ; Dunn RL; Roberts RO; Girman CJ; Lieber MM; Cooney KA; Schottenfeld D; Montie JE; Jacobsen SJ; ;
    Urology; 2003 Jun; 61(6):1086-91. PubMed ID: 12809866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
    Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
    BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.
    Jacobsen SJ; Jacobson DJ; McGree ME; St Sauver JL; Klee GG; Girman CJ; Lieber MM
    Mayo Clin Proc; 2012 Jan; 87(1):34-40. PubMed ID: 22212966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.
    Whittemore AS; Cirillo PM; Feldman D; Cohn BA
    J Urol; 2005 Sep; 174(3):872-6; discussion 876. PubMed ID: 16093978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.
    Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
    J Urol; 2010 Mar; 183(3):946-50. PubMed ID: 20083275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential selection bias in a community-based study of PSA levels in African-American men.
    Heeringa SG; Alcser KH; Doerr K; Strawderman M; Cooney K; Medbery B; Schottenfeld D
    J Clin Epidemiol; 2001 Feb; 54(2):142-8. PubMed ID: 11166529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and socioeconomic status are independently associated with benign prostatic hyperplasia.
    Fowke JH; Murff HJ; Signorello LB; Lund L; Blot WJ
    J Urol; 2008 Nov; 180(5):2091-6; discussion 2096. PubMed ID: 18804231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential effect of anti-inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy.
    Kryvenko ON; Wang Y; Sadasivan S; Gupta NS; Rogers C; Bobbitt K; Chitale DA; Rundle A; Tang D; Rybicki BA
    Prostate; 2019 Jul; 79(10):1090-1098. PubMed ID: 31045267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.
    Burke JP; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2006 Jan; 67(1):22-5. PubMed ID: 16413325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.